Showing 3 results for Disease
This announcement seeks revolutionary research ideas for topics not being
addressed by ongoing BTO programs or other published solicitations.
The goal of the DIGET program is to leverage advances in gene editing
technologies to develop low-cost, high-trust, sensitive, multiplexed,
rapidly reconfigurable, and fieldable diagnostics and biosurveillance
technologies to address the need for timely and comprehensive threat
detection surveillance to support Department of Defense (DoD) stabilization
missions and outpace infectious disease.
The goal of the NOW program is to develop a mobile medical countermeasure
(MCM) manufacturing platform for use in stabilization and humanitarian
operations to produce, formulate, and package hundreds of doses of nucleic
acid therapeutics (DNA and/or RNA) in less than 24 hours. The developed
platform should be a resilient, mobile, readily accessible nucleic acid MCM
manufacturing capability that enables immediate threat response anywhere the
military operates with minimal user intervention.